Company / Financials
ABEONA THERAPEUTICS INC. Financials
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$5.8M
FY2025 · +66.3% YoY
Net Income
$71.2M
FY2025 · +231.4% YoY
Profit Margin
1223.1%
FY2025 · net income / revenue
ROE
44.7%
FY2025 · return on equity
Total Assets
$219.6M
FY2025
Total Debt
$20.0M
0.13x debt/equity
Equity
$159.2M
FY2025
ROA
32.4%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score -2.42 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$5.8M+66.3% YoYNet Income HistoryProfit after all expenses and taxes$71.2M+231.4% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$1.5MOperating Income HistoryProfit from core business operations before interest and taxes-$89.4M-89.8% YoYSG&A Expense HistorySelling, general, and administrative expenses$65.0M+242.2% YoYR&D Expense HistoryResearch and development spending$26.8M-13.8% YoYInterest Expense HistoryCost of borrowing and debt obligations$3.7M+794.7% YoYIncome Tax HistoryTotal income tax expense$100.0KEPS (Basic) HistoryBasic earnings per share-$1.55+38.7% YoYEPS (Diluted) HistoryDiluted earnings per share including stock options and convertibles-$1.55+38.7% YoY